Powers Director of Government Relations Taryn Couture presented yesterday at the Academy of Managed Care Pharmacy (AMCP) Specialty Connect Meeting, a two-day program focused on specialty management in oncology.
In the presentation, Taryn discussed the current legislative and regulatory landscape regarding the use of utilization management strategies for oncologic treatments, including the impact of provisions like prior authorization and step therapy. The session also covered the rationale and impact of oral chemotherapy parity laws and federal guidance and state laws that impact the use of biosimilars in oncology.
Taryn will also present on a panel entitled “Perspectives on Providing Value in Oncology,” which will cover various stakeholder perspectives on value in oncology care and the use of utilization management programs from provider, regulatory, payer, and patient perspectives. Taryn will be joined by Oncology Analytics SVP Laura Bobolts, Magellan Rx Management Senior Director Rebecca Borgert, and National Patient Advocate Foundation’s VP for Advocacy Communications Christine Wilson. The panel will be moderated by Clifford Goodman of the Lewin Group.
The session will take place on November 10 at 3:00 pm EST. To learn more, click here.
Taryn can be reached at Taryn.Couture@PowersLaw.com
